Skip to main content

Global Vision Impairment Devices Market grows at 8% CAGR, fueled by refractive error cases 2030

 


The global Vision Impairment Devices Market is expected to grow at a rate of 8% to reach $5.5 billion by 2026. Increasing number of visual impairment & blindness, growing prevalence of eye disorders (such as diabetic retinopathy, refractive error, glaucoma, and cataract), rising awareness regarding assistive technologies for the visually challenged, and growing government initiatives for awareness & funding for the advanced devices are some of the key factors driving the growth of vision impairment devices market. However, a stringent regulatory requirement is a key challenge hindering the growth of the global visual impairment devices market.

Vision Impairment is the limitation of one or more eye functions or visual systems. This can range from mild vision impairment to total blindness. The most common causes of visual impairment are uncorrected refractive errors (near-sightedness, far-sightedness, presbyopia, and astigmatism), cataracts, and glaucoma.

Vision Impairment cannot be corrected to normal vision with surgery or prescriptive lenses like glasses or contacts. In such situations of visual impairment, assistive technologies for visual impairment can be used. These assistive technologies for visual impairment can be assistive, adaptive, and rehabilitative for people with disabilities.

Download a free sample report now 👉
https://meditechinsights.com/global-vision-impairment-devices-market/request-sample/

The Advent of Advanced Technologies for Visual Impairment Drives the Visual Impairment Devices Market

In the past years, the main option for visually impaired people for vision assistance was magnifying lenses. Today's assistive technology tools not only include better magnification devices, but also advanced software, apps, and other products that use facial recognition, artificial intelligence, augmented reality, and other technologies to tangibly improve the lives of the visually impaired. These technologies can be high tech and low tech, which can range from smart canes, wearables, reading helpers, and lever doorknobs to voice recognition software and augmentative communication devices (speech generating devices).

Different types of assistive technologies available in the market include video magnifiers, braille printers, braille watches, braille duplicators, mathematical & science devices, reading machines, bionic eye systems, low vision apps, and other low vision devices such as smart glasses, VTS links, and magnifying lenses which can help to improve and maintain the functional abilities of people with vision impairment. Recently, many developments have been made to improve the quality of life of visually impaired people such as:

  • In October 2021, Freedom Scientific announced the newest addition to its RUBY family, the RUBY 10, a 10-inch touch screen video magnifier with optional text to speech and advanced viewing modes.
  • In June 2021, Eyedaptic, Inc. announced Eye3, a new and improved version of its augmented reality eyewear designed for patients with age-related macular degeneration (AMD) and low vision.
  • In November 2020, Envision announced the official launch of its Envision Glasses, which are AI-powered smart glasses for blind and visually impaired people.
  • In July 2020, NovaSight secured $8 million in Series A financing to tackle vision disorders worldwide.

Growing awareness of visual impairment among the people, due to media and other social platforms, has resulted in driving the demand for assistive technologies for the visually impaired.

“Blindness or visual impairment can have a profound impact on one's life. New intuitive and intelligent solutions are emerging to address such conditions which can change the lives of people living with visual impairment and vision loss. Advancements in assistive technologies have a key role to play.” - VP Product Innovation, Design and Product Development, Vision Impairment Device Company, United States

North America Leads in terms of Adoption of Visual Impairment Devices Market

North America has the largest market share for vision impairment, followed by Europe and the Asia Pacific. An increase in the incidence of vision impairment among the population, a well-developed healthcare infrastructure, technological advancements in the devices and software to help the visually impaired population, and the presence of key market players in this region are some of the key factors driving the North American Visual Impairment Devices market.

Developed countries in Europe such as Germany, the UK, and France are expected to grow significantly over the forecast period due to the adoption of the latest technology, active engagement in designing new software for braille printers and writers, and the rising prevalence of eye disorders in this region. Asia Pacific region is expected to witness the fastest growth due to the increasing population of dire eye health conditions such as age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma commonly found in old age people. In addition to this, increasing investments and funding for research and development activities are also likely to spur the visual impairment devices market.

Unlock key data with a sample report for competitive analysis:
https://meditechinsights.com/global-vision-impairment-devices-market/request-sample/

Competitive Landscape Analysis: Visual Impairment Devices Market

Major players operating in the global visual impairment devices market include Adaptivation, Inc., AbleNet, Inc., Amedia Corporation, Access Ingenuity, LVI Low Vision International, American Thermoform, Cambium Learning, Quantum Technology, Optelec, Pixium-Vision, Dolphin Computer Access Ltd., Eyedaptic, Inc., HumanWare Group, ViewPlus, VFO, and Envision, among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in Visual Impairment Devices Market

The global vision impairment devices market is an emerging but competitive market marked by the presence of both established and new players. Players operating in the market adopt both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share.  For instance,

  • In February 2021,  EssilorLuxottica and Cooper Companies, two of the world’s leading vision care companies, announced the acquisition of SightGlass Vision, a U.S.-based life sciences company with the common goal of driving the commercialization of innovative myopia control technologies.
  • In January 2020, ViewPlus introduced the new Power-Dot Braille which is the strongest and most readable Braille dots available from any desktop braille embosser.

The vision impairment devices market is a growing market that is expected to gain further momentum in the coming years due to an increase in the development of smart technology, a favorable regulatory landscape, increasing investments from private equity, venture capitalists, and government globally, and aggressive organic and inorganic growth strategies followed by players.

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 
info@meditechinsights.com 

Comments

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...